News Advent Pharma Ltd.

Equities

ADVENT

BD0492ADVPL9

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
25.9 ^BDT	0.00%		-0.77%	+4.02%

04-29	Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-06	Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-28	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-06	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-13	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	29/10/23	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	15/05/23	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	13/02/23	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	24/11/22	CI
Advent Pharma Ltd. Completes Signing Agreement of Distributorship with Alltech Biotechnology Pvt Ltd	17/11/22	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	30/10/22	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	24/05/22	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	30/01/22	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	02/12/21	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	31/10/21	CI
Advent Pharma Ltd. Appoints Asif Iqbal Chowdhury as Chairman	06/05/21	CI
21,567,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2021.	11/04/21	CI
Advent Pharma Ltd. Appoints Faria Binte Alam as the Managing Director	02/07/20	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	24/03/20	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	04/02/20	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	29/01/20	CI
Advent Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	29/10/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Advent Pharma Ltd.

Equities

ADVENT

BD0492ADVPL9

Summary

Filters